GL Pharm Tech Corp. (KOSDAQ:204840)

South Korea flag South Korea · Delayed Price · Currency is KRW
924.00
-31.00 (-3.25%)
At close: Jun 1, 2026
Market Cap71.66B -32.0%
Revenue (ttm)36.86B +31.4%
Net Income-131.58M
EPS-1.81
Shares Out 77.55M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume325,099
Open955.00
Previous Close955.00
Day's Range899.00 - 955.00
52-Week Range890.00 - 1,352.00
Beta0.41
Analystsn/a
Price Targetn/a
Earnings DateAug 13, 2026

About GL Pharm Tech

GL Pharm Tech Corp. provides generic drugs and incrementally modified drug (IMD) formulation technology to pharmaceutical companies in South Korea. The company offers IMD for gastritis, antidepressant, anorectic, and antibiotic indications. It also provides generic drugs for cardiovascular, urology, pain, anti-infection, gastric disease, diabetes, central nervous system disease, respiratory disease, transplantation, and other areas. In addition, the company engages in developing new molecule entity pipeline products for dry eye disease. Further... [Read more]

Industry Pharmaceutical Preparations
Founded 2002
Employees 33
Stock Exchange KOSDAQ
Ticker Symbol 204840
Full Company Profile

Financial Performance

Financial Statements